M&A
AstraZeneca Makes Roughly $10 Billion Offer for Rhythm
AstraZeneca PLC has offered to buy Rhythm Pharmaceuticals Inc. for about $10 billion, according to people familiar with the matter, in a bid to…
Archive
biotech
Capital Raises
Dren Bio Raises $350 Million to Bring Blood Cancer Drug to Market
Dren Bio Inc., a privately held developer of antibody drugs, raised $350 million in an oversubscribed financing to carry its lead blood cancer treatment…